• Home
  • About
    • Mission & Overview
    • Our Team
    • Strategic Advisory Council
    • Veterans Advisory Council
    • Board of Directors
  • Brain Health
    • About Post-Traumatic Stress
    • About Traumatic Brain Injury
    • Patient & Veteran Perspectives
  • Programs
    • Our Programs
    • Roadmap
    • Advocacy
    • Publications & Resources
    • Traumatic Brain Injury
    • Post-Traumatic Stress Disorder
    • BRAIN Commons
    • Funding Opportunities
    • Legacy Programs
      • Multiple Sclerosis
      • – Orion MS 1.0
      • Biomarkers
      • – Resources
  • The Alliance
    • Cooperative Bionetwork
    • Our Sponsors
    • Our Partners
  • News & Events
    • News
    • Events
    • Webinars
    • Press
    • Newsletter
    • Brain Health Nexus
    • 22 Jumps
    • State of the Science Summit
    • Cohen Veterans Care Summit
  • Careers
  • Join The Fight
  • Donate
  • Contact
Cohen Veterans Bioscience
    • Home
    • About
      • Mission & Overview
      • Our Team
      • Strategic Advisory Council
      • Veterans Advisory Council
      • Board of Directors
    • Brain Health
      • About Post-Traumatic Stress
      • About Traumatic Brain Injury
      • Patient & Veteran Perspectives
    • Programs
      • Our Programs
      • Roadmap
      • Advocacy
      • Publications & Resources
      • Traumatic Brain Injury
      • Post-Traumatic Stress Disorder
      • BRAIN Commons
      • Funding Opportunities
      • Legacy Programs
        • Multiple Sclerosis
        • – Orion MS 1.0
        • Biomarkers
        • – Resources
    • The Alliance
      • Cooperative Bionetwork
      • Our Sponsors
      • Our Partners
    • News & Events
      • News
      • Events
      • Webinars
      • Press
      • Newsletter
      • Brain Health Nexus
      • 22 Jumps
      • State of the Science Summit
      • Cohen Veterans Care Summit
    • Careers
    • Join The Fight
    • Donate
    • Contact

    News

    Cohen Veterans Bioscience > News
    • Molecular Med Tri-Con conference logo

      Molecular Medicine Tri-Conference | February 15-20, 2015 | San Francisco, CA

      February 1, 2015

      The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.

      Read more
      Cohen Veterans Bioscience
    • FasterCures panel discussion photo

      Orion CEO Magali Haas Featured in Partnering for Cures panel: Unlocking the Mysteries of the Human Brain

      November 25, 2014

      What if we started diagnosing brain disorders based on physiological measures as opposed to the behavioral measures that are currently in use now? This is the provocative question that kicked off the five-person panel discussion at the sixth annual Partnering for Cures, moderated by Kafui Dzirasa of Duke University Medical Center.

      Read more
      Cohen Veterans Bioscience
    • Nature Neuroscience presents Focus on Big Data in their November issue

      November 6, 2014

      Nature Neuroscience presents a Focus on Big Data in their November Issue

      Read more
      Cohen Veterans Bioscience
    • Orion Alliance Leadership Member Philip De Jager, MD, PhD, Awarded the National MS Society’s 2014 Barancik Prize for Innovation in MS Research

      October 23, 2014

      Philip L. De Jager, MD, PhD, Neurologist at Brigham and Women’s Hospital and Associate Professor of Neurology at Harvard Medical School, is the 2014 recipient of the Barancik Prize for Innovation in MS Research, an international award established in 2013 to drive progress in multiple sclerosis (MS) research. Dr. De Jager, a clinician and a researcher, was selected for his work in applying powerful analytic approaches to better understand how genes and the environment interact with the goal of developing personalized treatments for MS and, ultimately, disease prevention.

      Read more
      Cohen Veterans Bioscience
    • Alzheimers & Dementia journal logo

      Orion CEO Co-Authors 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease

      October 20, 2014

      Orion CEO & Founder Magali Haas was a co-author of the Alzheimer’s Association 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease. Read the full report here: http://www.alzheimersanddementia.com/article/S1552-5260(14)02791-5/fulltext

      Read more
      Cohen Veterans Bioscience
    • Previous
    • 1
    • ...
    • 48
    • 49
    • 50
    • 51
    • 52
    • ...
    • 54
    • Next
    Help Us Make Brain Disorders Predictable, Treatable & Curable
    WHO WE ARE
    Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
    Learn More Donate
    LEARN MORE ABOUT OUR MISSION
    Get News & Updates

    Get Email Updates

    Guidestar Platinum Transparency 2021

    Member of the American Brain Coalition

    ©2022 Cohen Veterans Bioscience
    Powered by Tone Creative

    • Privacy Policy
    • Terms of Use
    • FCOI Policy
    • Indirect Cost Policy
    • Careers
    • Contact Us
    • Donate
    Manage Cookie Consent
    We use cookies to optimize our website.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View Preferences
    {title} {title} {title}
    Manage Cookie Consent
    We use cookies to optimize our website.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View Preferences
    {title} {title} {title}